Clinical importance of inducible beta-lactamases in gram-negative bacteria.
about
beta-Lactamases in laboratory and clinical resistanceActivity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsSingle amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme.Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting.OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods.Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.Susceptibility to beta-lactam antibiotics and gentamicin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study.
P2860
Q24669605-1438293C-84D7-4681-8CC6-CC3E2A4ECDF6Q35326845-CFA23BE3-F9B6-46A2-80F0-9A16B7641A6DQ36433259-BF3CB6A1-993F-4995-B28A-FCF5F42E1DA7Q36496456-8FEBDB71-232B-48CD-A971-6703663584DFQ36546934-CBAF1757-5AF3-4965-928B-966F20D28696Q36753213-FA692AA6-EB58-4F16-8F3F-B3E341B47211Q36757620-BB4C765A-E13A-4B2B-9769-8C3866D3C898Q39451907-AA58CF89-CBB0-4A9F-A8F3-739BDBADB78CQ39832242-84A31AE4-5DF3-4430-80EE-9FB7AF41C101Q40087113-55E9AF29-C933-44B3-AA19-2D36BB24AB7BQ54393970-5145A368-C578-4689-A895-0EAECCFA7209
P2860
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@en
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@nl
type
label
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@en
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@nl
prefLabel
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@en
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@nl
P2860
P356
P1476
Clinical importance of inducible beta-lactamases in gram-negative bacteria.
@en
P2093
C C Sanders
W E Sanders
P2860
P304
P356
10.1007/BF02013106
P577
1987-08-01T00:00:00Z